MARKET WIREYahoo Finance • 21h ago
MESA LABS DECLARES QUARTERLY DIVIDENDYahoo Finance report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
Why MLAB Stock dropped -4.57% Today — RQD Quant Desk Flash
$121.97 -4.57% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $120.73
Mesa Laboratories Inc. (MLAB) carries a Roarable Rating of C- (Hold) with 59/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
ROARABLE C- • HOLD / WATCH
Cap $715.2M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on MLAB Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is MLAB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Mesa Laboratories Inc. (NASDAQ: MLAB) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 59/100 at a spot price of $121.97 (-4.57% 1D, market cap $715.2M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 11/20, SEC Balance-Sheet Forensics 14/20, FRED Macro Regime Fit 13/20, and Executive Insider Alignment 11/20. Across 486 tracked Industrials issuers, MLAB ranks #134 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does MLAB compare to ENVX and EOSE in the Industrials sector?
▼
Within the Industrials sector (Industrial Machinery/Components), MLAB carries a Roarable C- (59/100 RQD), trailing P/E of 110.9x, gross margin of 63.5%, and ROIC of 9.3%. By comparison, ENVX (Enovix Corporation) holds a E grade (22/100 RQD, P/E N/A, ROIC -20.5%, cap $691.3M) and EOSE (Eos Energy Enterprises Inc. (Class A)) posts a E grade (20/100 RQD, P/E N/A, ROIC -35.0%, cap $688.3M). Among the 5-stock peer group, GHM leads on earnings multiple (67.3x) while GHM leads on capital efficiency (10.9% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for MLAB?
▼
Per MLAB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0000724004), Mesa Laboratories Inc. generated $249.1M in revenue (+3.4% YoY), $6.7M in net income, and $39.6M in free cash flow against $434.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Industrials with deep daily trading liquidity. Primary risk factors monitored: Priced at 111x earnings—high expectations leave less room for a lukewarm quarter. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $120.74 (-1.01%)🧬 Cannibal Buyback (-0.96% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 15.9% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 59/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.2% avg 90D alpha vs SPY • 53.1% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERHOLD / WATCH • C-
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D+ · Rk C+
Each axis scored 0–20
12M PRICE TARGET CONE+0.5% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MLAB)Realized 20D OHLCV Swing Band: ±7.2%
Deterministic 5-Pillar Attribution (59/100 Composite)
🔍 WHY MLAB SCORES 59/100 (C-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+14/20 pts (24% of score)
Altman Z-Score 2.07 (WATCH ZONE (1.8–3.0)) • Piotroski F-Score 7/9
▲ #2 Bullish Driver: Macro Regime Fit+13/20 pts (22% of score)
FRED Regime × Technicals: 70% of 52W Range • RSI-14 at 48.8 (NEUTRAL RANGE)
▼ #1 Drag / Risk Factor: Cash Engine Quality10/20 pts (-10 pt drag)
Capital intensity & 7.4% operating margin leave 10 pts on the table
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade B-$127.56-1.9% Next Q
67
Q2 (-2Q)Grade C+$125.16+3.3% Next Q
64
Q3 (-1Q)Grade C+$129.25-5.6% Next Q
62
CurrentGrade C-$121.97+0.2% Hist 90D α
59
Trajectory: B- (67) → C- (59)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the MLAB Bull Thesis Could Fail
Even with a 59/100 (C-) score, MLAB faces multiple-compression risk if 110.9x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Priced at 111x earnings—high expectations leave less room for a lukewarm quarter.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-0.96% YoY Shares) — any gross margin slip below 61.0% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($128.76) or 200D SMA ($104.60) invalidates the momentum regime and cuts Target Base ($122.52) toward Bear Floor ($95.57).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $MLAB• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “MLAB Beats Next Quarter EPS Consensus (Dec 29, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why MLAB Stock dropped -4.57% Today — RQD Quant Desk Flash
Mesa Laboratories Inc. (MLAB) dropped -4.57% to $121.97, trading at 70% of its 52-week range ($69.51 – $144.35). Solid 63.5% gross margin (9% return on capital), mixed timing at 111x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 70% of its 52-week range ($69.51 – $144.35) with RSI-14 at 48.8 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±7.2% around $121.97 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C- (Hold) backed by 63.5% gross margin and $39.6M annual free cash flow.
Live MLAB Headlines & Catalysts
MARKET WIRETradingView • 1d ago
Mesa Laboratories, Inc. Estimates – NASDAQ:MLABTradingView report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
CATALYSTmarketscreener.com • 1d ago
Mesa Laboratories Keeps Quarterly Dividend at $0.16 per Share, Payable Dec. 15 to Holders of Record Nov. 30marketscreener.com report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 1d ago
Mesa Labs Announces Second Quarter Financial Results Release Date and Earnings Conference CallYahoo Finance report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Titan • 1d ago
After a 1,200-share gift, Mesa Laboratories (MLAB) director Sullivan holds 19,418 shares directly.Stock Titan report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 1d ago
Mesa Laboratories to Lay Off 40 Positions; Targets $9.3 Million Annual Cost ReductionYahoo Finance report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Traders Daily • 1d ago
Behavioral Patterns of MLAB and Institutional FlowsStock Traders Daily report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
MARKET WIREdars.gov.et • 1d ago
Mesa Laboratories (MLAB) Slips 4.34% to $136.06, Nearing Key Support Zone - Put Supportdars.gov.et report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
MARKET WIRESeekingAlpha • 6d ago
Diamond Hill Small Cap Fund Q3 2026 Portfolio ActivityUtz Brands shares rose after entering into an agreement to be acquired by Intersnack, a privately held European leader in savory snacks.
CATALYSTYahoo • 21d ago
Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable GrowthThe Restructuring Program focuses Clinical Genomics on profitability and adds resources in Sterilization and Disinfection Control, Calibration Solutions and AsiaLAKEWOOD, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Mesa Lab
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (MLAB Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
MLAB // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +18.43%▲ ASCENDING CHANNEL
2026-11-03O $133.0H $133.0L $122.0C $122.0VOL 73.2K
RES: $155.5SUP: $106.3SMA50: $128.8SMA200: $104.6
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
MLAB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
48.0%/yr Implied 5Y Growth
vs. +3.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on MLAB today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for MLAB. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for MLAB today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MLAB)
Industrials Rank #134 of 486
⚔️ ENVX vs MLAB Full Matrix →
1. Head-to-Head Industrials Peer Comparison (MLAB vs. ENVX, EOSE, KRNT, GHM)
Industry: Industrial Machinery/Components (208 Tracked Issuers)Across 486 tracked Industrials securities in the Roarable RQD universe, Mesa Laboratories Inc. (MLAB) ranks #134 by composite RQD confidence (59/100, grade C-) and #277 by equity capitalization ($715.2M). Within this direct 5-issuer industry benchmark cohort, GHM leads on earnings valuation at 67.3x trailing P/E, while GHM leads on capital efficiency and profitability with 10.9% ROIC and 23.5% gross margin. MLAB currently leads its immediate peer cohort in composite quantitative strength at 59/100 (C-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| MLAB
ACTIVE
Mesa Laboratories Inc. | C- | 59/100 | 110.9x | 63.5% | 9.3% | -4.57% | $715.2M | Benchmark Subject |
| ENVX Enovix Corporation | E | 22/100 | — | 19.2% | -20.5% | -5.71% | $691.3M | /envx-vs-mlab → |
| EOSE Eos Energy Enterprises Inc. (Class A) | E | 20/100 | — | -30.0% | -35.0% | -6.88% | $688.3M | /eose-vs-mlab → |
| KRNT Kornit Digital Ltd. | D | 49/100 | — | 44.3% | -4.0% | -0.46% | $752.8M | /krnt-vs-mlab → |
| GHM Graham Corporation | D- | 37/100 | 67.3x | 23.5% | 10.9% | +1.10% | $821.0M | /ghm-vs-mlab → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2026-03-31 • CIK 0000724004 ↗In its most recent audited fiscal period (FY2025, filed 2026-03-31), Mesa Laboratories Inc. (MLAB) reported GAAP revenue of $249.1M (+3.4% vs. FY2024 revenue of $241.0M , and +15.2% cumulative change since FY2023) , GAAP net income of $6.7M, operating cash flow of $42.8M, and free cash flow of $39.6M (-7.0% YoY). On the balance sheet, MLAB closed FY2025 with $434.8M in total assets against $0 in total debt (Altman Z-Score: 2.07, Piotroski F-Score: 7/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2026-03-31 | $249.1M | $6.7M | $42.8M | $39.6M | $434.8M | — |
| FY2024 (FY) | 2025-03-31 | $241.0M | -$2.0M | $46.8M | $42.6M | $433.3M | — |
| FY2023 (FY) | 2024-03-31 | $216.2M | -$254.2M | $44.1M | $44.1M | — | — |
3. MLAB Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs MLAB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Mesa Laboratories Inc. (NASDAQ: MLAB) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 59/100 at a spot price of $121.97 (-4.57% 1D, market cap $715.2M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 11/20, SEC Balance-Sheet Forensics 14/20, FRED Macro Regime Fit 13/20, and Executive Insider Alignment 11/20. Across 486 tracked Industrials issuers, MLAB ranks #134 in composite RQD confidence.
How does MLAB compare to ENVX and EOSE in the Industrials sector?
Within the Industrials sector (Industrial Machinery/Components), MLAB carries a Roarable C- (59/100 RQD), trailing P/E of 110.9x, gross margin of 63.5%, and ROIC of 9.3%. By comparison, ENVX (Enovix Corporation) holds a E grade (22/100 RQD, P/E N/A, ROIC -20.5%, cap $691.3M) and EOSE (Eos Energy Enterprises Inc. (Class A)) posts a E grade (20/100 RQD, P/E N/A, ROIC -35.0%, cap $688.3M). Among the 5-stock peer group, GHM leads on earnings multiple (67.3x) while GHM leads on capital efficiency (10.9% ROIC).
What are the biggest fundamental strengths and SEC risk factors for MLAB?
Per MLAB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0000724004), Mesa Laboratories Inc. generated $249.1M in revenue (+3.4% YoY), $6.7M in net income, and $39.6M in free cash flow against $434.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Industrials with deep daily trading liquidity. Primary risk factors monitored: Priced at 111x earnings—high expectations leave less room for a lukewarm quarter. Institutional options positioning shows a 50% call / 50% put premium split.
Where is MLAB trading relative to its 50-day, 200-day, and 52-week technical levels?
MLAB last traded at $121.97 (-4.57% on volume of 153,282 shares), positioning the stock -5.27% below its 50-day simple moving average ($128.76) and +16.61% above its 200-day simple moving average ($104.60). Across its 52-week range of $69.51 to $144.35, MLAB sits at the 70.1% percentile with a 14-day RSI of 48.8 (NEUTRAL RANGE) and an implied next-earnings move of ±7.2% ($113.19 to $130.75).
ROARABLE RATING BRIEF • RQD 59/100 (C-)
✓ SEC XBRL & RQD VERIFIED
MLAB — Mesa Laboratories Inc.: What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2026-03-31
1. Roarable Rating Brief: What This Means to a Prospective Investor
Mesa Laboratories Inc. (MLAB) earns a live Roarable RQD composite score of 59/100, corresponding to a C- letter grade (Roarable Hold) at a spot price of $121.97 (-4.57% 1D, market capitalization $715.2M).
- Fundamental Cash Engine (10/20): Anchored by return on invested capital (ROIC) of 9.3%, gross margin of 63.5%, operating margin of 7.4%, and free cash flow yield of 5.32%.
- Whale 13F & Options Flow (11/20) + Insider Conviction (11/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (13/20) + Forensic Balance Sheet (14/20): Incorporates a 1.00x equity beta, Altman Z-Score of 2.07, Piotroski F-Score of 7/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
Mesa Laboratories Inc. Is a NASDAQ-listed issuer in the Industrials sector, operating within the Industrial Machinery/Components industry..7B.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2026-03-31), Mesa Laboratories Inc. (MLAB) reported $249.1M in annual revenue (up from $241.0M in FY2024, +3.4% YoY) and $6.7M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($216.2M revenue, -$254.2M net income) through FY2025, MLAB scaled operating cash flow to $42.8M and free cash flow to $39.6M, backed by $434.8M in total assets against $0 in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (C- • RQD 59/100): Established market leader in Industrials with deep daily trading liquidity. Free cash flow yield of 5.32% and institutional whale pillar of 11/20. With Fundamental Cash Engine at 10/20 and Institutional Whale Flow at 11/20, sustained execution supports upside toward the upper end of the $69.51 – $144.35 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Priced at 111x earnings—high expectations leave less room for a lukewarm quarter. Investors must weigh 110.9x trailing P/E and 33.6x EV/EBITDA against 7.4% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Sector classification (Industrials / Industrial Machinery/Components) is the only contextual link provided, so second-order ripples cannot be mapped from the sources. An investor should treat sector beta (1.0) as the only quantified macro linkage.
- Key Question #1: Can MLAB sustain or expand its 7.4% operating margin and 9.3% ROIC against Industrial Machinery/Components peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $249.1M and free cash flow of $39.6M, how will capital allocation balance growth reinvestment against $0 in total debt?
- Key Question #3: How sensitive is MLAB's 103.1x forward P/E multiple to Industrials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
MLAB Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Mesa Laboratories Inc. (MLAB) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo Finance • 21h ago
MESA LABS DECLARES QUARTERLY DIVIDEND Yahoo Finance report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 1d ago
Mesa Laboratories, Inc. Estimates – NASDAQ:MLAB TradingView report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST marketscreener.com • 1d ago
Mesa Laboratories Keeps Quarterly Dividend at $0.16 per Share, Payable Dec. 15 to Holders of Record Nov. 30 marketscreener.com report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 1d ago
Mesa Labs Announces Second Quarter Financial Results Release Date and Earnings Conference Call Yahoo Finance report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 1d ago
After a 1,200-share gift, Mesa Laboratories (MLAB) director Sullivan holds 19,418 shares directly. Stock Titan report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 1d ago
Mesa Laboratories to Lay Off 40 Positions; Targets $9.3 Million Annual Cost Reduction Yahoo Finance report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Traders Daily • 1d ago
Behavioral Patterns of MLAB and Institutional Flows Stock Traders Daily report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE dars.gov.et • 1d ago
Mesa Laboratories (MLAB) Slips 4.34% to $136.06, Nearing Key Support Zone - Put Support dars.gov.et report covering Mesa Laboratories Inc. (MLAB) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
MLAB Bull vs. Bear Conversation Board — What's Your Call at $121.97?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON MLAB 🐻 33% BEARISH CONVICTION
CA CashFlowKing RQD DEBATE OPENER • FCF Compounder Hunter 🐂 BULLISH
🎯 Target: $153.37 (+20.0%)
📌 Pinned Debate Per the RQD rating, the Forensic Balance Sheet pillar (14 / 20) is supported by Piotroski F of 7/9 and Debt/Equity of 0.5, and FCF has
Long MLAB at $127.81 targeting $153.37. Per the RQD rating, the Forensic Balance Sheet pillar (14 / 20) is supported by Piotroski F of 7/9 and Debt/Equity of 0.5, and FCF has been positive across all three reported periods.. Institutional whale score is 11/20 and the risk/reward vs. the $69.51 52-week low is skewed heavily in favor of bulls.
VolSurface_Trader 🐂 BULL
@CreditSpread_Watch Shorting a 11/20 institutional whale-flow stock at $127.81 is dangerous when funds are rotating into Industrials.
CR CreditSpread_Watch RQD DEBATE OPENER • Balance Sheet Analyst 🐻 BEARISH
🎯 Target: $100.97 (-21.0%)
Spot @ $127.81 Per the market data, P/E (TTM) of 110.9 and EV/EBITDA of 33.6 sit against ROIC of 9.3% and an FCF yield of 5.32%, leaving valuation thi
Here is the bear case nobody on the bull side wants to address on MLAB: Per the market data, P/E (TTM) of 110.9 and EV/EBITDA of 33.6 sit against ROIC of 9.3% and an FCF yield of 5.32%, leaving valuation thin relative to cash returns.. At 110.9x trailing P/E, even a small guidance miss in Industrial Machinery/Components triggers a 12-15% air pocket.